Authors:
GRANERUS G
LONNQVIST B
KALLBERG M
KAGEDAL B
Citation: G. Granerus et al., DAY-TO-DAY VARIATION IN URINARY-EXCRETION OF THE HISTAMINE METABOLITEMETHYLIMIDAZOLEACETIC ACID, Inflammation research, 47, 1998, pp. 52-53
Authors:
SVEDJEHOLM R
DAHLIN LG
LUNDBERG C
SZABO Z
KAGEDAL B
NYLANDER E
OLIN C
RUTBERG H
Citation: R. Svedjeholm et al., ARE ELECTROCARDIOGRAPHIC Q-WAVE CRITERIA RELIABLE FOR DIAGNOSIS OF PERIOPERATIVE MYOCARDIAL-INFARCTION AFTER CORONARY SURGERY, European journal of cardio-thoracic surgery, 13(6), 1998, pp. 655-661
Authors:
MEYERHOFFER S
LINDBERG Z
HAGER A
KAGEDAL B
ROSDAHL I
Citation: S. Meyerhoffer et al., URINARY-EXCRETION OF 5-S-CYSTEINYLDOPA AND 6-HYDROXY-5-METHOXYINDOLE-2-CARBOXYLIC ACID IN CHILDREN, Acta dermato-venereologica, 78(1), 1998, pp. 31-35
Authors:
KARNELL R
VONSCHOULTZ E
HANSSON LO
NILSSON B
ARSTRAND K
KAGEDAL B
Citation: R. Karnell et al., S100B PROTEIN, 5-S-CYSTEINYLDOPA AND 6-HYDROXY-5-METHOXYINDOLE-2-CARBOXYLIC ACID AS BIOCHEMICAL MARKERS FOR SURVIVAL PROGNOSIS IN PATIENTS WITH MALIGNANT-MELANOMA, Melanoma research, 7(5), 1997, pp. 393-399
Citation: I. Rosdahl et al., VITAMIN-A METABOLISM AND MESSENGER-RNA EXPRESSION OF RETINOID-BINDINGPROTEIN AND RECEPTOR GENES IN HUMAN EPIDERMAL MELANOCYTES AND MELANOMA-CELLS, Melanoma research, 7(4), 1997, pp. 267-274
Citation: N. Dizdar et al., EFFECTS ON INTERSTITIAL GLUTATHIONE, CYSTEINE AND 5-S-CYSTEINYLDOPA OF BUTHIONINE SULFOXIMINE IN HUMAN-MELANOMA TRANSPLANTS, Melanoma research, 7(4), 1997, pp. 322-328
Authors:
SIRSJO A
KAGEDAL B
ARSTRAND K
LEWIS DH
NYLANDER G
GIDLOF A
Citation: A. Sirsjo et al., ALTERED GLUTATHIONE LEVELS IN ISCHEMIC AND POSTISCHEMIC SKELETAL-MUSCLE - DIFFERENCE BETWEEN SEVERE AND MODERATE ISCHEMIC INSULT, The journal of trauma, injury, infection, and critical care, 41(1), 1996, pp. 123-128
Authors:
SIRSJO A
ARSTRAND K
KAGEDAL B
NYLANDER G
GIDLOF A
Citation: A. Sirsjo et al., IN-SITU MICRODIALYSIS FOR MONITORING OF EXTRACELLULAR GLUTATHIONE LEVELS IN NORMAL, ISCHEMIC AND POSTISCHEMIC SKELETAL-MUSCLE, Free radical research, 25(5), 1996, pp. 385-391
Authors:
KARLSSON M
BOERYD B
CARSTENSEN J
FRANLUND B
GUSTAFSSON B
KAGEDAL B
SUN XF
WINGREN S
Citation: M. Karlsson et al., CORRELATIONS OF KI-67 AND PCNA TO DNA-PLOIDY, S-PHASE FRACTION AND SURVIVAL IN UVEAL MELANOMA, European journal of cancer, 32A(2), 1996, pp. 357-362
Authors:
SWENNE I
ERIKSSON UJ
CHRISTOFFERSSON R
KAGEDAL B
LUNDQUIST P
NILSSON L
TYLLESKAR T
ROSLING H
Citation: I. Swenne et al., CYANIDE TOXIFICATION IN RATS EXPOSED TO ACETONITRILE AND FED A LOW-PROTEIN DIET, Fundamental and applied toxicology, 32(1), 1996, pp. 66-71
Citation: E. Andersson et al., MALIGNANT-MELANOMA CELLS EXHIBIT DIFFERENCES IN VITAMIN-A METABOLISM AND MESSENGER-RNA-EXPRESSION OF RETINOID-BINDING PROTEIN AND RECEPTOR GENES AS COMPARED TO HUMAN MELANOCYTES, Journal of investigative dermatology, 107(3), 1996, pp. 64-64
Authors:
KARLSSON M
JUNGNELIUS U
AAMDAL S
BOERYD B
CARSTENSEN J
KAGEDAL B
WESTBERG R
WINGREN S
Citation: M. Karlsson et al., CORRELATION OF DNA-PLOIDY AND S-PHASE FRACTION WITH CHEMOTHERAPEUTIC RESPONSE AND SURVIVAL IN A RANDOMIZED STUDY OF DISSEMINATED MALIGNANT-MELANOMA, International journal of cancer, 65(1), 1996, pp. 1-5
Citation: P. Lundquist et al., AN IMPROVED METHOD FOR DETERMINATION OF THIOCYANATE IN PLASMA AND URINE, European journal of clinical chemistry and clinical biochemistry, 33(6), 1995, pp. 343-349
Authors:
KARLSSON M
BOERYD B
CARSTENSEN J
KAGEDAL B
WINGREN S
Citation: M. Karlsson et al., DNA-PLOIDY AND S-PHASE FRACTION AS PROGNOSTIC FACTORS IN PATIENTS WITH UVEAL MELANOMAS, British Journal of Cancer, 71(1), 1995, pp. 177-181
Authors:
SVEDJEHOLM R
DAHLIN LG
LUNDBERG C
KAGEDAL B
NYLANDER E
OLIN C
RUTBERG H
Citation: R. Svedjeholm et al., ARE ELECTROCARDIOGRAPHIC Q-WAVE CRITERIA RELIABLE FOR DIAGNOSIS OF PERIOPERATIVE MYOCARDIAL-INFARCTION (PMI) IN CARDIAC-SURGERY, British Journal of Anaesthesia, 74, 1995, pp. 22-22
Authors:
LUNDQUIST P
KAGEDAL B
NILSSON L
ROSLING H
Citation: P. Lundquist et al., ANALYSIS OF THE CYANIDE METABOLITE 2-AMINOTHIAZOLINE-4-CARBOXYLIC ACID IN URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Analytical biochemistry, 228(1), 1995, pp. 27-34
Authors:
KAGEDAL B
KONRADSSON P
SHIBATA T
MISHIMA Y
Citation: B. Kagedal et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF DOPACHROME AND DIHYDROXYPHENYLALANINE, Analytical biochemistry, 225(2), 1995, pp. 264-269
Authors:
SJOLINFORSBERG G
HANSSON C
KAGEDAL B
GANNEDAHL EL
BERNE B
Citation: G. Sjolinforsberg et al., URINARY-EXCRETION OF MELANOCYTE METABOLITES DURING TREATMENT WITH CHLOROQUINE PHOSPHATE, Acta dermato-venereologica, 75(4), 1995, pp. 287-289
Authors:
KARLSSON M
BOERYD B
CARSTENSEN J
KAGEDAL B
WINGREN S
Citation: M. Karlsson et al., DNA-PLOIDY AND S-PHASE FRACTION IN PRIMARY MELANOMAS AND THEIR REGIONAL METASTASES, Melanoma research, 4(1), 1994, pp. 47-51
Citation: L. Nilsson et B. Kagedal, LIPOAMIDASE AND BIOTINIDASE ACTIVITIES IN THE RAT - TISSUE DISTRIBUTION AND INTRACELLULAR-LOCALIZATION, European journal of clinical chemistry and clinical biochemistry, 32(7), 1994, pp. 501-509
Authors:
CARLSSON MS
DENNEBERG T
EMANUELSSON BM
KAGEDAL B
LINDGREN S
Citation: Ms. Carlsson et al., PHARMACOKINETICS OF 2-MERCAPTOPROPIONYLGLYCINE (TIOPRONIN) IN PATIENTS WITH IMPAIRED RENAL-FUNCTION, Drug investigation, 7(2), 1994, pp. 101-112
Authors:
CARLSSON MS
DENNEBERG T
EMANUELSSON BM
KAGEDAL B
LINDGREN S
Citation: Ms. Carlsson et al., STEADY-STATE PHARMACOKINETICS OF 2-MERCAPTOPROPIONYLGLYCINE (TIOPRONIN) IN HEALTHY-VOLUNTEERS AND PATIENTS WITH CYSTINURIA, Drug investigation, 7(1), 1994, pp. 41-51